BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1045 related articles for article (PubMed ID: 31623665)

  • 1. Tumor-infiltrating B cells affect the progression of oropharyngeal squamous cell carcinoma via cell-to-cell interactions with CD8
    Hladíková K; Koucký V; Bouček J; Laco J; Grega M; Hodek M; Zábrodský M; Vošmik M; Rozkošová K; Vošmiková H; Čelakovský P; Chrobok V; Ryška A; Špíšek R; Fialová A
    J Immunother Cancer; 2019 Oct; 7(1):261. PubMed ID: 31623665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PD-L1 expression correlates with tumor-infiltrating lymphocytes and better prognosis in patients with HPV-negative head and neck squamous cell carcinomas.
    Sanchez-Canteli M; Granda-Díaz R; Del Rio-Ibisate N; Allonca E; López-Alvarez F; Agorreta J; Garmendia I; Montuenga LM; García-Pedrero JM; Rodrigo JP
    Cancer Immunol Immunother; 2020 Oct; 69(10):2089-2100. PubMed ID: 32448984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Significance of PD-L1
    Solomon B; Young RJ; Bressel M; Urban D; Hendry S; Thai A; Angel C; Haddad A; Kowanetz M; Fua T; Corry J; Fox S; Rischin D
    Cancer Immunol Res; 2018 Mar; 6(3):295-304. PubMed ID: 29378694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic impact of p16 and PD-L1 expression in patients with oropharyngeal squamous cell carcinoma receiving a definitive treatment.
    Sato F; Ono T; Kawahara A; Kawaguchi T; Tanaka H; Shimamatsu K; Kakuma T; Akiba J; Umeno H; Yano H
    J Clin Pathol; 2019 Aug; 72(8):542-549. PubMed ID: 31113825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD8+ T Cells and PD-L1 Expression as Prognostic Indicators in a Low Prevalence of HPV-Associated Oropharyngeal Squamous Cell Carcinoma.
    Atipas K; Laokulrath N; Petsuksiri J; Ratanaprasert N; Pongsapich W
    Curr Oncol; 2023 Jan; 30(2):1450-1460. PubMed ID: 36826072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HPV Epitope Processing Differences Correlate with ERAP1 Allotype and Extent of CD8
    Reeves E; Wood O; Ottensmeier CH; King EV; Thomas GJ; Elliott T; James E
    Cancer Immunol Res; 2019 Jul; 7(7):1202-1213. PubMed ID: 31151965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD8
    Masterson L; Lechner M; Loewenbein S; Mohammed H; Davies-Husband C; Fenton T; Sudhoff H; Jani P; Goon P; Sterling J
    Eur J Cancer; 2016 Nov; 67():141-151. PubMed ID: 27669501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PD-L1 Expression and a High Tumor Infiltrate of CD8+ Lymphocytes Predict Outcome in Patients with Oropharyngeal Squamous Cells Carcinoma.
    Wuerdemann N; Gültekin SE; Pütz K; Wittekindt C; Huebbers CU; Sharma SJ; Eckel H; Schubotz AB; Gattenlöhner S; Büttner R; Speel EJ; Klussmann JP; Wagner S; Quaas A
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32718057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A beneficial tumor microenvironment in oropharyngeal squamous cell carcinoma is characterized by a high T cell and low IL-17(+) cell frequency.
    Punt S; Dronkers EA; Welters MJ; Goedemans R; Koljenović S; Bloemena E; Snijders PJ; Gorter A; van der Burg SH; Baatenburg de Jong RJ; Jordanova ES
    Cancer Immunol Immunother; 2016 Apr; 65(4):393-403. PubMed ID: 26899388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oropharyngeal squamous cell carcinomas differentially express granzyme inhibitors.
    van Kempen PM; Noorlag R; Swartz JE; Bovenschen N; Braunius WW; Vermeulen JF; Van Cann EM; Grolman W; Willems SM
    Cancer Immunol Immunother; 2016 May; 65(5):575-85. PubMed ID: 26993499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of immune makers with HPV 16 infections and the prognosis in oropharyngeal squamous cell carcinoma.
    Zhu Y; Zhu X; Diao W; Liang Z; Gao Z; Chen X
    Clin Oral Investig; 2023 Apr; 27(4):1423-1433. PubMed ID: 36884083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The tumor immune microenvironment and its implications for clinical outcome in patients with oropharyngeal squamous cell carcinoma.
    Gurin D; Slavik M; Hermanova M; Selingerova I; Kazda T; Hendrych M; Shatokhina T; Vesela M
    J Oral Pathol Med; 2020 Oct; 49(9):886-896. PubMed ID: 32516834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of Immunological Characteristics and Genomic Alterations in HPV-Positive Oropharyngeal Squamous Cell Carcinoma Based on PD-L1 Expression.
    Xu SM; Shi CJ; Xia RH; Wang LZ; Tian Z; Ye WM; Liu L; Liu SL; Zhang CY; Hu YH; Zhou R; Han Y; Wang Y; Zhang ZY; Li J
    Front Immunol; 2021; 12():798424. PubMed ID: 35145511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stromal infiltration of CD8 T cells is associated with improved clinical outcome in HPV-positive oropharyngeal squamous carcinoma.
    Oguejiofor K; Hall J; Slater C; Betts G; Hall G; Slevin N; Dovedi S; Stern PL; West CM
    Br J Cancer; 2015 Sep; 113(6):886-93. PubMed ID: 26313665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD8-alpha T-cell infiltration in human papillomavirus-related oropharyngeal carcinoma correlates with improved patient prognosis.
    Jung AC; Guihard S; Krugell S; Ledrappier S; Brochot A; Dalstein V; Job S; de Reynies A; Noël G; Wasylyk B; Clavel C; Abecassis J
    Int J Cancer; 2013 Jan; 132(2):E26-36. PubMed ID: 22890882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significant association of PD-L1 expression with human papillomavirus positivity and its prognostic impact in oropharyngeal cancer.
    Hong AM; Ferguson P; Dodds T; Jones D; Li M; Yang J; Scolyer RA
    Oral Oncol; 2019 May; 92():33-39. PubMed ID: 31010620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation and characterisation of prognostically significant PD-L1
    Young RJ; Bressel M; Porceddu S; Cernelc J; Savas P; Liu H; Urban D; Thai AA; Cooper C; Fua T; Neeson P; Rischin D; Solomon B
    Oral Oncol; 2020 Feb; 101():104516. PubMed ID: 31838340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD8+ T Cell Infiltration Predicts Chemoradiosensitivity in Nasopharyngeal or Oropharyngeal Cancer.
    Kawaguchi T; Ono T; Sato F; Kawahara A; Kakuma T; Akiba J; Sato K; Chitose SI; Umeno H
    Laryngoscope; 2021 Apr; 131(4):E1179-E1189. PubMed ID: 32930399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peritumoral cuffing by T-cell tumor-infiltrating lymphocytes distinguishes HPV-related oropharyngeal squamous cell carcinoma from oral cavity squamous cell carcinoma.
    Poropatich K; Hernandez D; Fontanarosa J; Brown K; Woloschak G; Paintal A; Raparia K; Samant S
    J Oral Pathol Med; 2017 Nov; 46(10):972-978. PubMed ID: 28632936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spatial proximity between T and PD-L1 expressing cells as a prognostic biomarker for oropharyngeal squamous cell carcinoma.
    Tsakiroglou AM; Fergie M; Oguejiofor K; Linton K; Thomson D; Stern PL; Astley S; Byers R; West CML
    Br J Cancer; 2020 Feb; 122(4):539-544. PubMed ID: 31806878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 53.